The Potential Role of Vedolizumab in Concomitant Eosinophilic Esophagitis and Crohn's Disease

Affiliations

¹ Division of Gastroenterology and Hepatology, Department of Medicine, Northwestern University, Chicago, Illinois.
² Section of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Rush University Medical Center, Chicago, Illinois.

Comment

Tiffany H Taft et al. Clin Gastroenterol Hepatol. 2018 Nov.

. 2018 Nov;16(11):1840-1841.

doi: 10.1016/j.cgh.2018.06.022.

¹ Division of Gastroenterology and Hepatology, Department of Medicine, Northwestern University, Chicago, Illinois.
² Section of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Rush University Medical Center, Chicago, Illinois.

No abstract available

Comment in

Reply.
Mukkada VA. Mukkada VA. Clin Gastroenterol Hepatol. 2018 Nov;16(11):1841-1842. doi: 10.1016/j.cgh.2018.07.015. Clin Gastroenterol Hepatol. 2018. PMID: 30343869 No abstract available.

Health-Related Quality of Life and Costs Associated With Eosinophilic Esophagitis: A Systematic Review.
Mukkada V, Falk GW, Eichinger CS, King D, Todorova L, Shaheen NJ. Mukkada V, et al. Clin Gastroenterol Hepatol. 2018 Apr;16(4):495-503.e8. doi: 10.1016/j.cgh.2017.06.036. Epub 2017 Jun 24. Clin Gastroenterol Hepatol. 2018. PMID: 28655543
Vedolizumab Treatment May Reduce Steroid Burden and Improve Histology in Patients With Eosinophilic Gastroenteritis.
Kim HP, Reed CC, Herfarth HH, Dellon ES. Kim HP, et al. Clin Gastroenterol Hepatol. 2018 Dec;16(12):1992-1994. doi: 10.1016/j.cgh.2018.03.024. Epub 2018 Mar 27. Clin Gastroenterol Hepatol. 2018. PMID: 29596982 Free PMC article. No abstract available.